Literature DB >> 18767960

The role of aminoacyl-tRNA synthetases in genetic diseases.

Anthony Antonellis1, Eric D Green.   

Abstract

Aminoacyl-tRNA synthetases (ARSs) are ubiquitously expressed, essential enzymes responsible for performing the first step of protein synthesis. Specifically, ARSs attach amino acids to their cognate tRNA molecules in the cytoplasm and mitochondria. Recent studies have demonstrated that mutations in genes encoding ARSs can result in neurodegeneration, raising many questions about the role of these enzymes (and protein synthesis in general) in neuronal function. In this review, we summarize the current knowledge of genetic diseases that are associated with mutations in ARS-encoding genes, discuss the potential pathogenic mechanisms underlying these disorders, and point to likely areas of future research that will advance our understanding about the role of ARSs in genetic diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18767960     DOI: 10.1146/annurev.genom.9.081307.164204

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  134 in total

1.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.

Authors:  Heather M McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehlivan; Kristine Chu; Ram Iyer; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; James C Mullikin; Leslie G Biesecker; Thomas E Wilson; Victor Ionasescu; Garth Nicholson; Charles Searby; Kevin Talbot; Jeffrey M Vance; Stephan Züchner; Kinga Szigeti; James R Lupski; Ya-Ming Hou; Eric D Green; Anthony Antonellis
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

Review 2.  Glomerular diseases: genetic causes and future therapeutics.

Authors:  Chih-Kang Chiang; Reiko Inagi
Journal:  Nat Rev Nephrol       Date:  2010-07-20       Impact factor: 28.314

3.  A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).

Authors:  Ah Jung Seo; Youn Ho Shin; Seo Jin Lee; Doyeun Kim; Byung Sun Park; Sunghoon Kim; Kyu Ha Choi; Na Young Jeong; Chan Park; Ji-Yeon Jang; Youngbuhm Huh; Junyang Jung
Journal:  J Mol Histol       Date:  2013-08-30       Impact factor: 2.611

4.  A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N).

Authors:  Heather M McLaughlin; Reiko Sakaguchi; William Giblin; Thomas E Wilson; Leslie Biesecker; James R Lupski; Kevin Talbot; Jeffery M Vance; Stephan Züchner; Yi-Chung Lee; Marina Kennerson; Ya-Ming Hou; Garth Nicholson; Anthony Antonellis
Journal:  Hum Mutat       Date:  2011-11-09       Impact factor: 4.878

Review 5.  Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.

Authors:  Rebecca Meyer-Schuman; Anthony Antonellis
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

Review 6.  Genetic approaches to the treatment of inherited neuromuscular diseases.

Authors:  Bhavya Ravi; Anthony Antonellis; Charlotte J Sumner; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

7.  Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures.

Authors:  Xiaochang Zhang; Jiqiang Ling; Giulia Barcia; Lili Jing; Jiang Wu; Brenda J Barry; Ganeshwaran H Mochida; R Sean Hill; Jill M Weimer; Quinn Stein; Annapurna Poduri; Jennifer N Partlow; Dorothée Ville; Olivier Dulac; Tim W Yu; Anh-Thu N Lam; Sarah Servattalab; Jacqueline Rodriguez; Nathalie Boddaert; Arnold Munnich; Laurence Colleaux; Leonard I Zon; Dieter Söll; Christopher A Walsh; Rima Nabbout
Journal:  Am J Hum Genet       Date:  2014-03-20       Impact factor: 11.025

8.  MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.

Authors:  Jonathan Rips; Rebecca Meyer-Schuman; Oded Breuer; Reuven Tsabari; Avraham Shaag; Shoshana Revel-Vilk; Shimon Reif; Orly Elpeleg; Anthony Antonellis; Tamar Harel
Journal:  Eur J Med Genet       Date:  2018-04-12       Impact factor: 2.708

9.  A homozygous truncating mutation in PUS3 expands the role of tRNA modification in normal cognition.

Authors:  Ranad Shaheen; Lu Han; Eissa Faqeih; Nour Ewida; Eman Alobeid; Eric M Phizicky; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-04-07       Impact factor: 4.132

10.  A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2.

Authors:  Junya Nakajima; Tuba F Eminoglu; Goksel Vatansever; Mitsuko Nakashima; Yoshinori Tsurusaki; Hirotomo Saitsu; Hisashi Kawashima; Naomichi Matsumoto; Noriko Miyake
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.